Stop-Loss Insurers Signal Continued Pricing Pressure Through 2027.

𝗠𝗮𝗿𝗸𝗲𝘁 𝗦𝗶𝗴𝗻𝗮𝗹

Recent commentary from Sun Life, Voya, and Cigna points to a common theme: stop-loss carriers have implemented substantial rate corrections in response to a surge in catastrophic claims during 2024. Several carriers cited double-digit rate increases across 2025 and 2026, with some expecting elevated pricing pressure to continue through one additional renewal cycle before moderating toward more typical trend levels.

𝗛𝗣𝗫 𝗣𝗲𝗿𝘀𝗽𝗲𝗰𝘁𝗶𝘃𝗲

What stands out is not the rate increases themselves, but rather the market's response to them. Despite significant repricing, stop-loss sales continued to grow. Sun Life reported a 43% increase in stop-loss sales, suggesting that employer demand for self-funded and alternative funding arrangements remains strong. Employers appear increasingly willing to absorb higher stop-loss costs in exchange for the flexibility, transparency, and long-term economic advantages of strategic risk financing.

𝗪𝗵𝘆 𝗜𝘁 𝗠𝗮𝘁𝘁𝗲𝗿𝘀

The more important takeaway is that all three stories ultimately point to the same underlying issue: rising claim severity. Stop-loss carriers are not raising rates arbitrarily. They are responding to a healthcare environment characterized by higher-cost specialty drugs, advanced therapies, and increasingly expensive catastrophic claims. Insurance pricing is simply reflecting the economics of healthcare delivery.

𝗟𝗼𝗼𝗸𝗶𝗻𝗴 𝗔𝗵𝗲𝗮𝗱

As alternative funding strategies continue to gain adoption, employers may need to think beyond risk financing alone. The organizations best positioned to sustain attractive health benefits over the coming decade will be those that pair alternative funding with unbundled contracting strategies that actively address the drivers of claim severity. While strategic risk financing determines how risk is funded, healthcare delivery strategy determines how much risk exists in the first place. Employers that optimize both will likely be best positioned to manage cost, improve patient experience, and sustain benefits appeal in an increasingly complex healthcare market.